US20100210788A1 - Electron deficient olefins - Google Patents

Electron deficient olefins Download PDF

Info

Publication number
US20100210788A1
US20100210788A1 US12/766,457 US76645710A US2010210788A1 US 20100210788 A1 US20100210788 A1 US 20100210788A1 US 76645710 A US76645710 A US 76645710A US 2010210788 A1 US2010210788 A1 US 2010210788A1
Authority
US
United States
Prior art keywords
group
alkyl
aryl
cyanoacrylate
cyanoacrylates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/766,457
Inventor
Ciaran B. McArdle
Ligang Zhao
Stefano Gherardi
Kevin Murnaghan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel IP and Holding GmbH
Original Assignee
Henkel Loctite Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Loctite Ireland Ltd filed Critical Henkel Loctite Ireland Ltd
Priority to US12/766,457 priority Critical patent/US20100210788A1/en
Publication of US20100210788A1 publication Critical patent/US20100210788A1/en
Assigned to HENKEL IRELAND LIMITED reassignment HENKEL IRELAND LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GHERARDI, STEFANO L., MCARDLE, CIARAN B., MURNAGHAN, KEVIN D., ZHAO, LIGANG
Assigned to LOCTITE (R&D) LIMITED reassignment LOCTITE (R&D) LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HENKEL IRELAND LIMITED
Assigned to HENKEL IRELAND HOLDING B.V. reassignment HENKEL IRELAND HOLDING B.V. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: LOCTITE (R&D) LIMITED
Assigned to HENKEL IRELAND LIMITED reassignment HENKEL IRELAND LIMITED MERGER (SEE DOCUMENT FOR DETAILS). Assignors: HENKEL IRELAND HOLDING B.V.
Assigned to HENKEL AG & CO. KGAA reassignment HENKEL AG & CO. KGAA MERGER (SEE DOCUMENT FOR DETAILS). Assignors: HENKEL IRELAND LIMITED
Assigned to Henkel IP & Holding GmbH reassignment Henkel IP & Holding GmbH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HENKEL AG & CO. KGAA
Priority to US14/663,722 priority patent/US20150191424A1/en
Priority to US14/945,843 priority patent/US9481640B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/15Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same unsaturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/17Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and doubly-bound oxygen atoms bound to the same acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/593Dicarboxylic acid esters having only one carbon-to-carbon double bond
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/30Nitriles
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/13Phenols; Phenolates

Definitions

  • This invention relates to novel electron deficient olefins, such as certain 2-cyanoacrylates or methylidene malonates, prepared using an imine or an iminium salt.
  • Cyanoacrylate adhesives are known for their fast adhesion and ability to bond a wide variety of substrates. They are marketed as “super glue” type adhesives. They are useful as an all-purpose adhesive since they are a single component adhesive, very economical as only a small amount will do, and generally do not require any equipment to effectuate curing.
  • cyanoacrylate monomers have been produced by way of a Knoevenagel condensation reaction between a formaldehyde precursor, such as paraformaldehyde, and an alkyl cyanoacetate with a basic catalyst. During the reaction, cyanoacrylate monomer forms and polymerises in situ to a prepolymer. The prepolymer is subsequently thermally cracked or depolymerised, yielding cyanoacrylate monomer.
  • This approach has remained essentially the same over time, though various improvements and variants have been introduced. See e.g. U.S. Pat. Nos. 6,245,933, 5,624,699, 4,364,876, 2,721,858, 2,763,677 and 2,756,251.
  • U.S. Pat. No. 5,703,267 defines a process for producing a 2-cyanoacrylic acid which comprises subjecting a 2-cyanoacrylate and an organic acid to a transesterification reaction.
  • U.S. Pat. No. 5,455,369 defines an improvement in a process for preparing methyl cyanoacrylate, in which methyl cyanoacetate is reacted with formaldehyde to form a polymer that is then depolymerized to the monomeric product, and in which the purity of yield is 96% or better.
  • the improvement of the '369 patent is reported to be conducting the process in a poly(ethylene glycol)diacetate, dipropionate, or dibutyrate, having a number average molecular weight of 200-400, as the solvent.
  • U.S. Pat. No. 6,096,848 defines a process for the production of a biscyanoacrylate, which comprises the steps of esterifying a 2-cyanoacrylic acid or transesterifying an alkyl ester thereof to obtain a reaction mixture; and fractionally crystallizing the reaction mixture to obtain the biscyanoacrylate.
  • U.S. Pat. No. 4,587,059 defines a process for the preparation of monomeric 2-cyanoacrylates comprising the steps of (a) reacting (i) a 2,4-dicyanoglutarate with (ii) formaldehyde, cyclic or linear polymers of formaldehyde, or a mixture thereof, in the presence of between about 0.5 and about 5 mols of water per mol of 2,4-dicyanoglutarate, at an acid pH of about 3 to slightly less than 7, and at a temperature of about 70 to about 140, to form an oligomeric intermediate product, and (b) removing water that is present from step (a) and thermolyzing the oligomeric intermediate product for a period of time sufficient to effect its conversion to monomeric 2-cyanoacrylates.
  • cyanoacrylate esters bearing moisture, base, acid, thermally sensitive or otherwise reactive moieties may not be conveniently produced and isolated under Knoevenagel reaction conditions.
  • cyanoacrylates with reactive functionality in the ester side chain are known (see e.g. Buck and U.S. Pat. Nos. 3,975,422, 3,903,055, 4,003,942, 4,012,402, and 4,013,703)
  • the cyanoacrylates with reactive functionality in the ester side chain are prepared in a multi-step process involving protective group strategies and functional group transformations to arrive at adducts which must subsequently be deprotected to yield cyanoacrylates with additional functionality.
  • the same approach has been described to arrive at a cyanoacrylate-capped polyisobutylene by Kennedy et al., J. Macromol Sci. Chem., A28, 209 (1991).
  • U.S. Pat. No. 5,142,098 describes a copper catalysed reaction of malonates and formaldehyde to form methylidenemalonate monomers that are trapped in situ by a “diene” anthracene in a Diels-Alder reaction.
  • the '098 patent describes a diester adduct of anthracene, that is a precursor for a methylidenemalonate monomer with one ethyl ester and one glycidyl ester.
  • the '098 patent indicates that reaction—a retro Diels-Alder thermolysis step—was not successful for the preparation of the particular methylidene malonate bearing the glycidyl functionality in the ester side chain.
  • the retro Diels-Alder reaction has been reported as useful in the syntheses of other methylidene malonates (see e.g. J-L. De Keyser et al., J. Org. Chem., 53, 4859 (1988)).
  • the present invention provides novel electron deficient olefins, such as 2-cyanoacrylates or methylidene malonates, with a reactive functional group in the ester side chain, prepared using an imine or an iminium salt.
  • novel compounds are electron deficient olefins within structure I:
  • X is (a) an electron withdrawing group
  • n 0 or 1.
  • g is 1. However, if g>1, D is should be H.
  • D is selected from H, alkyl or aryl
  • n is 0 or 1
  • A, B, 1, 2, 3, 4, 5, and 6 are each references to bond designations.
  • Z is a reactive functionality
  • n is 0 or 1 and g is 1.
  • the reactive functionality of Z in structure III may be selected from epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, succinimides, 2-cyanoacrylates, methyiidene malonates, acrylonitrile, (meth)acrylates, carboxylic acids and derivatives thereof, cyanoacetates, methylene malonates, hydroxyls, silanes, siloxanes, titanates, or zirconates.
  • the present invention also provides compositions of the compounds of structures I, together with a stabilizer package comprising at least one of a free radical stabilizer and an anionic stabilizer; and optionally, one or more additives selected from cure accelerators, thickeners, thixotropes, tougheners, thermal resistance-conferring agents, or plasticizers.
  • the present invention further provides compositions of the compounds of structures I, II or III, together with a cyanoacrylate or a methylidene malonate.
  • the present invention further provides compositions of certain of the compounds of structures I, II or III, together with a coreactant, such as one selected from epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, (meth)acrylates, cyanoacrylates, methylidene malonates or vinyl ethers.
  • a coreactant such as one selected from epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, (meth)acrylates, cyanoacrylates, methylidene malonates or vinyl ether
  • FIG. 1 depicts a synthetic scheme by which iminium salts may be prepared.
  • FIG. 2 depicts a synthetic scheme by which a precursor to an inventive electron deficient olefin may be prepared.
  • FIG. 3 depicts a synthetic scheme by which the precursor to an inventive electron deficient olefin (from FIG. 2 ) is used with the iminium salt (from FIG. 1 ) to form the inventive electron deficient olefin.
  • the present invention provides electron deficient olefins within structure I:
  • X is (a) an electron withdrawing group, or (b) Y;
  • n 0 or 1.
  • g is 1. However, if g>1, D is should be H.
  • X is an electron withdrawing group (such as CN, CO 2 R, CO 2 H, COCl, COR, COPO(OR) 2 , COPOR 2 , SO 2 R, SO 3 R or NO 2 , where R is C 1-4 ) or E, E is as shown,
  • D is selected from H, alkyl or aryl
  • n is 0 or 1
  • A, B, 1, 2, 3, 4, 5, and 6 are each references to bond designations.
  • Q may be an amide or thioamide embraced by
  • T is O or S and U or V are each independently selected from H or R, where R is C 1-4 .
  • the vinyl group labeled ‘6’ is disposed 6 bond lengths distance from the vinyl group labeled ‘1’, ignoring side branches and where Q is not H.
  • X is an electron withdrawing group (such as CN, CO 2 R, CO 2 H, COCl, COR, COPO(OR) 2 , COPOR 2 , SO 2 R, SO 3 R or NO 2 , where R is C 1-4 ) or F, D is selected from H, alkyl or aryl, Z is a reactive functionality, n is 0 or 1 and g is 1.
  • the reactive functionality of Z in structure III may be selected from epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, succinimides, 2-cyanoacrylates, methylidene malonates, acrylonitrile, (meth)acrylates, carboxylic acids and derivatives thereof, cyanoacetates, methylene malonates, hydroxyls, silanes, siloxanes, titanates, or zirconates.
  • novel electron deficient olefins within the scope of the invention include
  • R 1 -R 2 , A-B, E, R 3 , w, y and z are as defined above.
  • the iminium salt embraced within structure VII is as follows:
  • the iminium salt is embraced more specifically by structure VIIA as follows:
  • R 1 -R 2 , A-B, E, R 3 , w, y and z, and X are as defined above.
  • the imine in some cases may be an imine having an onium salt, such as an ammonium or amine salt functionality.
  • the imines may be termed an “ionic liquid” (or “IL”) or a task specific ionic liquid (or, “TSIL”), as will be discussed in more detail below.
  • the iminium salts may be termed an “ionic liquid” (or “IL”) or a task specific ionic liquid (or, “TSIL”), as will be discussed in more detail below.
  • the imine of structure VI or the iminium salt of structure VII is particularly stable at room temperature conditions when in the presence of the precursor to the electron deficient olefin, a modest amount of heat may be useful to allow the reaction to generate electron deficient olefins. Exposure to elevated temperature conditions is particularly desirable with iminium salts of structure VII.
  • an aldehyde compound having the structure R 3 R 4 C ⁇ O, where R 3 is hydrogen and R 4 is a hydrogen, vinyl or propargyl.
  • the aldehyde compound may be an aldehyde itself or a source of an aldehyde, such as one that yields an aldehyde like formaldehyde under appropriate reaction conditions.
  • the aldehyde compound in a desirable embodiment includes formaldehyde or a source thereof, such as paraformaldehyde (see FIG. 1 ), formalin, or 1,3,5-trioxane, or vinyl aldehydes, such as acrolein.
  • a reactant with such an aldehyde is a primary amine.
  • Primary amines attached to a carbon bearing no alpha protons are particularly desirable, such as t-alkyl primary amines.
  • Rohm and Haas Co., Philadelphia, Pa. has sold commercially for a number of years a series of t-alkyl primary amines, which are designated as PRIMENE-brand amines.
  • t-alkyl primary amines available from Rohm and Haas include PRIMENE 81-R and PRIMENE JM-T. These PRIMENE-brand t-alkyl primary amines have highly branched alkyl chains (represented schematically by circle symbols in the Figures for simplicity) in which the amino nitrogen atom is attached directly to a tertiary carbon. These t-alkyl primary amines consist of mixtures of isomeric amines, with PRIMENE 81-R consisting of an isomeric mixture with C 12 -C 14 carbon branches and having an average molecular weight of 185 and PRIMENE JM-T consisting of an isomeric mixture with C 16 -C 22 carbon branches and having average molecular weight of 269.
  • PRIMENE MD also known as menthanediamine (1,8-diamino-p-menthane) or (4-amino- ⁇ , ⁇ -4-trimethyl-cyclohexanemethanamine, CAS No. 80-52-4
  • menthanediamine is a primary alicyclic diamine, in which both amino groups are attached to tertiary carbon atoms.
  • menthanediamine is somewhat less reactive than similar straight chain diamines.
  • PRIMENE TOA has tertiary octyl chains and a molecular weight of 129.
  • PRIMENE 81-R MSA iminium salt formed in reaction (2) of FIG. 1 , is used.
  • the imines whether or not bearing ammonium salt functionality or whether or not they are tethered to a support, are then reacted with compounds containing a methylene linkage having at least one, desirably two, electron withdrawing substituent(s) attached thereto.
  • a methylene compound useful as a precursor to an electron deficient olefin is depicted in FIG. 2 , which illustrates the esterification of cyanoacetic acid with alpha hydroxymethyl acrylate.
  • the electron withdrawing substituent is selected from nitrile, carboxylic acids, carboxylic esters, sulphonic or suphinic acids or their esters, ketones, phosphocarbonyl, or nitro.
  • Such compounds are reacted with iminium salts for example as depicted in FIG. 3 to form novel electron deficient olefins.
  • these compounds have two or more electron withdrawing substituents, which may be the same or different, such as nitrile and carboxylic acid ester—in this case, a cyanoacrylate.
  • the reactivity of these compounds in large part depends on the degree of electron withdrawing capability of the particular substituent, and the number of substituents on the active methylene carbon.
  • the reaction to form the novel electron deficient olefins may proceed with or without heating or cooling, depending of course on the specific reactants and the scale of the reaction.
  • Decomposition of the source of formaldehyde e.g., paraformaldehyde
  • the temperature may be reached through an external heating element or internally by means of the exotherm that may be generated, depending of course on the identity of the reactants.
  • the temperature of the reaction should be controlled however to accommodate any such exothermic processes.
  • the time of reaction may be monitored by reference to the formation of the desired novel electron deficient olefin product.
  • a 1 H NMR spectrometer is a particularly useful tool in this regard.
  • the time of reaction may be as little as 1 minute, for instance, or longer or shorter for that matter depending again on the identity of the specific, reactants, the scale of the reaction and whether heat is introduced to or removed from the reaction conditions.
  • the novel electron deficient olefin may be isolated by direct distillation under vacuum out of the reaction mixture or by freezing it in a solid form and separating off the liquid phase.
  • novel electron deficient olefin may be stabilized during the synthesis and/or isolation procedure, and also in the isolated product to improve its shelf life.
  • Suitable stabilizers include stabilizer packages that may contain one or more of free radical stabilizers and acidic stabilizers.
  • free radical stabilizers include hydroquinone, pyrocatechol, resorcinol or derivatives thereof, such as hydroquinone monoethyl ether, or phenols, such as di-t-butylphenol or 2,6-di-t-butyl-p-cresol, 2,2′-methylene-bis-(4-methyl-6-t-butylphenol), bisphenol A, dihydroxydiphenylmethane, and styrenized phenols.
  • hydroquinone pyrocatechol
  • resorcinol or derivatives thereof such as hydroquinone monoethyl ether
  • phenols such as di-t-butylphenol or 2,6-di-t-butyl-p-cresol, 2,2′-methylene-bis-(4-methyl-6-t-butylphenol), bisphenol A, dihydroxydiphenylmethane, and styrenized phenols.
  • acidic stabilizers include sulfuric acid, hydrochloric acid, sulfonic acids, such as methane, ethane or higher sulfonic acids, p-toluene sulfonic acid, phosphoric acid or polyphosphoric acids, silyl esters of strong acids, such as trialkyl chlorosilanes, dialkyl dichlorosilanes, alkyl trichlorosilanes, tetrachlorosilane, trialkyl silylsulfonic acids, trialkyl silyl-p-toluene sulfonates, bis-trialkyl silylsulfate and trialkyl silylphosphoric acid esters.
  • sulfonic acids such as methane, ethane or higher sulfonic acids, p-toluene sulfonic acid, phosphoric acid or polyphosphoric acids
  • silyl esters of strong acids such as trialkyl chlorosilanes
  • the amount of either stabilizer used to stabilize the electron deficient olefin prepared by the inventive processes is well known to those of ordinary skill in the art, and may be varied depending on the properties of the resulting composition made from the so formed electron deficient olefin.
  • the present invention also provides compositions of the compounds of structures I, II or III, together with a stabilizer package comprising at least one of a free radical stabilizer and an anionic stabilizer; and optionally, one or more additives selected from cure accelerators, thickeners, thixotropes, tougheners, thermal resistance-conferring agents, or plasticizers.
  • the cure accelerators that may be included with the inventive electron deficient olefins to form inventive compositions include calixarenes and oxacalixarenes, silacrowns, crown ethers, cyclodextrins, poly(ethyleneglycol) di(meth)acrylates, ethoxylated hydric compounds and combinations thereof.
  • calixarenes those within the following structure are useful herein:
  • R 1 is alkyl, alkoxy, substituted alkyl or substituted alkoxy
  • R 2 is H or alkyl
  • n is 4, 6 or 8.
  • calixarene is tetrabutyl tetra[2-ethoxy-2-oxoethoxy]calix-4-arene.
  • crown ethers A host of crown ethers are known.
  • examples which may be used herein include 15-crown-5,18-crown-6, dibenzo-18-crown-6, benzo-15-crown-5-dibenzo-24-crown-8, dibenzo-30-crown-10, tribenzo-18-crown-6, asym-dibenzo-22-crown-6, dibenzo-14-crown-4, dicyclohexyl-18-crown-6, dicyclohexyl-24-crown-8, cyclohexyl-12-crown-4, 1,2-decalyl-15-crown-5,1,2-naphtho-15-crown-5,3,4,5-naphtyl-16-crown-5,1,2-methyl-benzo-18-crown-6,1,2-methylbenzo-5,6-methylbenzo-18-crown-6,1,2-t-butyl-18-crown-6,1,2-vinylbenzo-15-
  • silacrowns again many are known, and are reported in the literature.
  • a typical silacrown may be represented within the following structure:
  • R 3 and R 4 are organo groups which do not themselves cause polymerization of the cyanoacrylate monomer
  • R 5 is H or CH 3 and n is an integer of between 1 and 4.
  • suitable R 3 and R 4 groups are R groups, alkoxy groups, such as methoxy, and aryloxy groups, such as phenoxy.
  • the R 3 and R 4 groups may contain halogen or other substituents, an example being trifluoropropyl.
  • groups not suitable as R 4 and R 5 groups are basic groups, such as amino, substituted amino and alkylamino.
  • cyclodextrins may be used in connection with the present invention.
  • those described and claimed in U.S. Pat. No. 5,312,864 (Wenz), the disclosure of which is hereby expressly incorporated herein by reference, as hydroxyl group derivatives of an ⁇ -, ⁇ - or ⁇ -cyclodextrin which is at least partly soluble in the cyanoacrylate would be appropriate choices for use herein as the first accelerator component.
  • poly(ethylene glycol) di(meth)acrylates suitable for use herein include those within the following structure:
  • n is greater than 3, such as within the range of 3 to 12, with n being 9 as particularly desirable. More specific examples include PEG 200 DMA (where n is about 4), PEG 400 DMA (where n is about 9), PEG 600 DMA (where n is about 14), and PEG 800 DMA (where n is about 19), where the number (e.g., 400) represents the average molecular weight of the glycol portion of the molecule, excluding the two methacrylate groups, expressed as grams/mole (i.e., 400 g/mol).
  • a particularly desirable PEG DMA is PEG 400 DMA.
  • ethoxylated hydric compounds or ethoxylated fatty alcohols that may be employed
  • appropriate ones may be chosen from those within the following structure:
  • C m can be a linear or branched alkyl or alkenyl chain
  • m is an integer between 1 to 30, such as from 5 to 20
  • n is an integer between 2 to 30, such as from 5 to 15, and R in this connection may be H or alkyl, such as C 1-6 alkyl.
  • DEHYDOL 100 Commercially available examples of materials within the above structure include those offered under the DEHYDOL tradename from Henkel KGaA, Dusseldorf, Germany, such as DEHYDOL 100.
  • the cure accelerator should be included in the compositions in an amount within the range of from about 0.01% to about 10% by weight, with the range of about 0.1 to about 0.5% by weight being desirable, and about 0.4% by weight of the total composition being particularly desirable.
  • inventive electron deficient olefins may be included with inventive electron deficient olefins to form inventive compositions to confer additional physical properties, such as improved shock resistance, thickness (for instance, polymethyl methacrylate), thixotropy (for instance fumed silica), color, and enhanced resistance to thermal degradation
  • maleimide compounds such as N,N′-meta-phenylene bismaleimide (see U.S. Pat. No. 3,988,299 (Malofsky)
  • certain mono, poly or hetero aromatic compounds characterized by at least three substitutions on an aromatic ring thereof, two or more of which being electron withdrawing groups see U.S. Pat. No. 5,288,794 (Attarwala)
  • certain quinoid compounds see U.S. Pat. No.
  • alkylating agents such as polyvinyl benzyl chloride, 4-nitrobenzyl chloride, and combinations thereof, silylating agents, and combinations thereof (see U.S. Pat. No. 6,093,780 (Attarwala)), the disclosures of each of which are hereby incorporated herein by reference.
  • Such additives therefore may be selected from certain acidic materials (like citric acid), thixotropy or gelling agents, thickeners, dyes, thermal degradation resistance enhancers, and combinations thereof. See e.g. U.S. patent application Ser. No. 11/119,703 and U.S. Pat. Nos. 5,306,752, 5,424,344 and 6,835,789, the disclosures of each of which are hereby incorporated herein by reference.
  • additives may be used in the inventive compositions individually in an amount from about 0.05% to about 20%, such as about 1% to 15%, desirably 5% to 10% by weight, depending of course on the identity of the additive.
  • citric acid may be used in the inventive compositions in an amount of 5 to 500 ppm, desirably 10 to 100 ppm.
  • inventive electron deficient olefins may render it less desirable to include one or more these additives with the inventive electron deficient olefins to form inventive compositions.
  • the present invention further provides compositions of the inventive compounds, together with a cyanoacrylate, a methylidene malonate or combinations thereof.
  • cyanoacrylate used in combination with the inventive compounds is one within structure IV:
  • R 1 is selected from C 1-16 alkyl, alkoxyalkyl, cycloalkyl, alkenyl (such as allyl), alkynyl, arylalkyl, aryl, or haloalkyl groups.
  • the cyanoacrylate with structure IV is selected from methyl cyanoacrylate, ethyl-2-cyanoacrylate, propyl cyanoacrylates, butyl cyanoacrylates, octyl cyanoacrylates, allyl cyanoacrylate, ⁇ -methoxyethyl cyanoacrylate and combinations thereof.
  • methylidene malonate used in combination with the inventive compounds is one within structure V:
  • R 2 and R 3 are each independently selected from C 1-16 alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl or haloalkyl groups.
  • the present invention further provides compositions of certain of the compounds of structure I, together with a coreactant, such as one selected from epoxides (such as cycloaliphatic epoxies), episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, (meth)acrylates, acrylamides, cyanoacrylates, methylidene malonates or vinyl ethers.
  • a coreactant such as one selected from epoxides (such as cycloaliphatic epoxies), episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, (meth)acrylates, acrylamides, cyanoacrylates, methylidene malonates or vinyl ethers.
  • PRIMENE 81-R imine was prepared by reaction of PRIMENE 81-R amine with a stoichiometric equivalent of paraformaldehyde and removal of water of condensation. All imines formed were distillable liquids and existed in stable monomeric imine forms as confirmed by 1 H NMR 60 MHz (CDCl 3 ) 2H s (br) 7.45 ppm and FTIR (1650 cm ⁇ 1 ).
  • PRIMENE 81-R iminium-MSA was prepared from PRIMENE 81-R imine by adding dropwise with stirring methane sulfonic acid at ice water bath temperature, yielding a pale yellow iminium salt.
  • reaction product was washed consecutively with 30% brine and water.
  • organic layer was dried over anhydrous sodium sulfate, filtered and the solvent removed by rotary evaporator.
  • the crude reaction product was purified by vacuum distillation (120-126° C./0.2 mbar), with the ester of structure A (102 g, 0.52 mol) isolated in a 52% yield.
  • reaction product was washed consecutively with 30% brine and water, and the organic layer was dried over anhydrous sodium sulfate, filtered and the solvent removed by rotary evaporator.
  • the crude reaction product was purified by vacuum distillation (98-100° C./0.1 mbar) and the ester, C was isolated in 80% yield.
  • reaction product was washed consecutively with 30% brine and water, and the organic layer was dried over anhydrous sodium sulfate, filtered and the solvent removed by rotary evaporator.
  • the crude reaction product was purified by vacuum distillation (86-88° C./0.05 mbar) and 7.5 g, 38 mmol of the ester, D was isolated in 49% yield.
  • the table below shows the starting intermediate, the resulting electron deficient olefin, the purity of the resulting electron deficient olefin and the yield in which some of the electron deficient olefins described above were obtained.

Abstract

This invention relates to novel electron deficient olefins, such as certain 2-cyanoacrylates and methylidene malonates, prepared using an imine or an iminium salt.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • This invention relates to novel electron deficient olefins, such as certain 2-cyanoacrylates or methylidene malonates, prepared using an imine or an iminium salt.
  • 2. Brief Description of Related Technology
  • Cyanoacrylate adhesives are known for their fast adhesion and ability to bond a wide variety of substrates. They are marketed as “super glue” type adhesives. They are useful as an all-purpose adhesive since they are a single component adhesive, very economical as only a small amount will do, and generally do not require any equipment to effectuate curing.
  • Traditionally, cyanoacrylate monomers have been produced by way of a Knoevenagel condensation reaction between a formaldehyde precursor, such as paraformaldehyde, and an alkyl cyanoacetate with a basic catalyst. During the reaction, cyanoacrylate monomer forms and polymerises in situ to a prepolymer. The prepolymer is subsequently thermally cracked or depolymerised, yielding cyanoacrylate monomer. This approach has remained essentially the same over time, though various improvements and variants have been introduced. See e.g. U.S. Pat. Nos. 6,245,933, 5,624,699, 4,364,876, 2,721,858, 2,763,677 and 2,756,251.
  • In U.S. Pat. No. 3,142,698, the synthesis of difunctional cyanoacrylates using a Knoevenagel condensation reaction is described. However, the ability to thermally depolymerise the resulting, now crosslinked, prepolymer in a reliable and reproducible manner to produce pure difunctional monomers in high yields is questionable [see J. Buck, J. Polym. Sci., Polym. Chem. Ed., 16, 2475-2507 (1978), and U.S. Pat. Nos. 3,975,422, 3,903,055, 4,003,942, 4,012,402, and 4,013,703].
  • A variety of other processes for producing cyanoacrylate monomers are known, some of which are described below. For instance, U.S. Pat. No. 5,703,267 defines a process for producing a 2-cyanoacrylic acid which comprises subjecting a 2-cyanoacrylate and an organic acid to a transesterification reaction.
  • U.S. Pat. No. 5,455,369 defines an improvement in a process for preparing methyl cyanoacrylate, in which methyl cyanoacetate is reacted with formaldehyde to form a polymer that is then depolymerized to the monomeric product, and in which the purity of yield is 96% or better. The improvement of the '369 patent is reported to be conducting the process in a poly(ethylene glycol)diacetate, dipropionate, or dibutyrate, having a number average molecular weight of 200-400, as the solvent.
  • U.S. Pat. No. 6,096,848 defines a process for the production of a biscyanoacrylate, which comprises the steps of esterifying a 2-cyanoacrylic acid or transesterifying an alkyl ester thereof to obtain a reaction mixture; and fractionally crystallizing the reaction mixture to obtain the biscyanoacrylate.
  • U.S. Pat. No. 4,587,059 defines a process for the preparation of monomeric 2-cyanoacrylates comprising the steps of (a) reacting (i) a 2,4-dicyanoglutarate with (ii) formaldehyde, cyclic or linear polymers of formaldehyde, or a mixture thereof, in the presence of between about 0.5 and about 5 mols of water per mol of 2,4-dicyanoglutarate, at an acid pH of about 3 to slightly less than 7, and at a temperature of about 70 to about 140, to form an oligomeric intermediate product, and (b) removing water that is present from step (a) and thermolyzing the oligomeric intermediate product for a period of time sufficient to effect its conversion to monomeric 2-cyanoacrylates.
  • Commercial production of cyanoacrylate monomers ordinarily relies on the depolymerisation of a prepolymer formed under Knoevenagel condensation reaction conditions, as noted above. Still today the Knoevenagel condensation reaction is believed to remain the most efficient and prevalent commercial method for producing high yields of monofunctional cyanoacrylates. Nevertheless, it would be desirable to not have to resort to thermally induced depolymerisation of a prepolymer produced by the Knoevenagel condensation reaction. This prospect may also enable facile access to highly useful difunctional monomers, such as so-called biscyanaocrylates or hybrid materials of cyanoacrylate and other polymerisable or reactive functionality.
  • For instance, cyanoacrylate esters bearing moisture, base, acid, thermally sensitive or otherwise reactive moieties, may not be conveniently produced and isolated under Knoevenagel reaction conditions.
  • While methods describing the preparation of cyanoacrylates with reactive functionality in the ester side chain (such as biscyanoacrylates) are known (see e.g. Buck and U.S. Pat. Nos. 3,975,422, 3,903,055, 4,003,942, 4,012,402, and 4,013,703), the cyanoacrylates with reactive functionality in the ester side chain are prepared in a multi-step process involving protective group strategies and functional group transformations to arrive at adducts which must subsequently be deprotected to yield cyanoacrylates with additional functionality. The same approach has been described to arrive at a cyanoacrylate-capped polyisobutylene by Kennedy et al., J. Macromol Sci. Chem., A28, 209 (1991).
  • A transesterification approach to achieve cyanoacrylates with reactive functions in the ester side chain has also been described in U.S. Pat. No. 6,096,848, in which cyanoacrylate esters, previously made by Knoevenagel reaction, are hydrolysed in strong acid conditions in the presence of a difunctional alcohol to yield biscyanoacrylates. The method described in the '848 patent requires long reaction times, copious volumes of solvent and solvent switching methods to isolate the bifunctional cyanoacrylates free from acid stablisers in modest to low yields [see also Khrustalev et al., Russian Chem. Bull., 45, 9, 2172 (1996)].
  • An alternative approach to the preparation of cyanoacrylates with reactive functions in the ester side chain uses cyanoacrylic acid or its acid chloride (cyanoacryloyl chloride). See e.g. International Patent Publication Nos. WO 94/15590A1, WO 94/115907A1, and WO 95/32183A1, and U.S. Pat. No. 5,703,267.
  • The use of cyanoacrylic acid and cyanoacryloyl chloride to arrive at cyanoacrylates has also been described in Y. Gololobov and I. Chernoglazova, Russian Chem. Bull., 42, 5, 961 (1993) and Y. Gololobov and M. Galkina, Russian Chem. Bull., 44, 4, 760 (1995). These methods require flash vacuum pyrolysis techniques conducted in quartz tubes at high temeperatures (approximately 600° C.) and exposure of highly reactive, polymerisable intermediate materials to chemical reactions with highly acidic and moisture sensitive reagents.
  • With regard to the preparation of other types of electron deficient olefins with reactive functionality, U.S. Pat. No. 5,142,098 describes a copper catalysed reaction of malonates and formaldehyde to form methylidenemalonate monomers that are trapped in situ by a “diene” anthracene in a Diels-Alder reaction. The '098 patent describes a diester adduct of anthracene, that is a precursor for a methylidenemalonate monomer with one ethyl ester and one glycidyl ester. The '098 patent indicates that reaction—a retro Diels-Alder thermolysis step—was not successful for the preparation of the particular methylidene malonate bearing the glycidyl functionality in the ester side chain. The retro Diels-Alder reaction has been reported as useful in the syntheses of other methylidene malonates (see e.g. J-L. De Keyser et al., J. Org. Chem., 53, 4859 (1988)).
  • Accordingly, it will be appreciated that the preparation of electron deficient olefins, such as 2-cyanoacrylates or methylidene malonates, with a reactive functional group in the ester, or even with large or bulky groups in the ester side chain, is not a trivial matter.
  • As a result and because of the limitations of the hitherto known various processes for cyanoacrylate synthesis and the sensitivity of the novel electron deficient olefins, such novel electron deficient olefins have not been described to date. Until now.
  • SUMMARY OF THE INVENTION
  • Unlike the state of the technology, the present invention provides novel electron deficient olefins, such as 2-cyanoacrylates or methylidene malonates, with a reactive functional group in the ester side chain, prepared using an imine or an iminium salt.
  • The novel compounds are electron deficient olefins within structure I:
  • Figure US20100210788A1-20100819-C00001
  • where X is (a) an electron withdrawing group, or
  • (b) Y;
  • Y is
  • Figure US20100210788A1-20100819-C00002
      • where D is selected from H, alkyl or aryl, Z is either
        • (i)
  • Figure US20100210788A1-20100819-C00003
      • where Q is
        • a. an electron withdrawing group (such as CN, CO2R, CO2H, COCl, COR, COPO(OR)2, COPOR2, SO2R, SO3R or NO2) or
        • b. a first reactive functionality, or
      • (ii) a second reactive functionality, g is 1-10; and
  • n is 0 or 1.
  • Desirably, g is 1. However, if g>1, D is should be H.
  • More specifically, the inventive compounds are embraced by structure II
  • Figure US20100210788A1-20100819-C00004
  • where X is an electron withdrawing group or E, E is as shown,
  • Figure US20100210788A1-20100819-C00005
  • is a reactive functionality, D is selected from H, alkyl or aryl, n is 0 or 1, and A, B, 1, 2, 3, 4, 5, and 6 are each references to bond designations.
  • In an alternative aspect the inventive compounds are embraced by structure III
  • Figure US20100210788A1-20100819-C00006
  • where X is an electron withdrawing group or F, D is selected from H, alkyl or aryl, Z is a reactive functionality, n is 0 or 1 and g is 1. The reactive functionality of Z in structure III may be selected from epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, succinimides, 2-cyanoacrylates, methyiidene malonates, acrylonitrile, (meth)acrylates, carboxylic acids and derivatives thereof, cyanoacetates, methylene malonates, hydroxyls, silanes, siloxanes, titanates, or zirconates.
  • The present invention also provides compositions of the compounds of structures I, together with a stabilizer package comprising at least one of a free radical stabilizer and an anionic stabilizer; and optionally, one or more additives selected from cure accelerators, thickeners, thixotropes, tougheners, thermal resistance-conferring agents, or plasticizers.
  • The present invention further provides compositions of the compounds of structures I, II or III, together with a cyanoacrylate or a methylidene malonate. Or the present invention further provides compositions of certain of the compounds of structures I, II or III, together with a coreactant, such as one selected from epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, (meth)acrylates, cyanoacrylates, methylidene malonates or vinyl ethers.
  • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 depicts a synthetic scheme by which iminium salts may be prepared.
  • FIG. 2 depicts a synthetic scheme by which a precursor to an inventive electron deficient olefin may be prepared.
  • FIG. 3 depicts a synthetic scheme by which the precursor to an inventive electron deficient olefin (from FIG. 2) is used with the iminium salt (from FIG. 1) to form the inventive electron deficient olefin.
  • DETAILED DESCRIPTION OF THE INVENTION
  • As noted above, the present invention provides electron deficient olefins within structure I:
  • Figure US20100210788A1-20100819-C00007
  • where X is (a) an electron withdrawing group, or (b) Y;
  • Y is
  • Figure US20100210788A1-20100819-C00008
  • where D is selected from H, alkyl or aryl, Z is either
      • (i)
  • Figure US20100210788A1-20100819-C00009
  • where Q is
      • a. an electron withdrawing group (such as CN, CO2R, CO2H, COCl, COR, COPO(OR)2, COPOR2, SO2R, SO3R or NO2) or
      • b. a first reactive functionality, or
      • (ii) a second reactive functionality, g is 1-10; and
  • n is 0 or 1.
  • Desirably, g is 1. However, if g>1, D is should be H.
  • More specifically, the inventive compounds are embraced by structure II
  • Figure US20100210788A1-20100819-C00010
  • where X is an electron withdrawing group (such as CN, CO2R, CO2H, COCl, COR, COPO(OR)2, COPOR2, SO2R, SO3R or NO2, where R is C1-4) or E, E is as shown,
  • Figure US20100210788A1-20100819-C00011
  • is a reactive functionality, D is selected from H, alkyl or aryl, n is 0 or 1, and A, B, 1, 2, 3, 4, 5, and 6 are each references to bond designations. Q may be an amide or thioamide embraced by

  • C(T)NUV,
  • where T is O or S and U or V are each independently selected from H or R, where R is C1-4. In addition, in structure II, the vinyl group labeled ‘6’ is disposed 6 bond lengths distance from the vinyl group labeled ‘1’, ignoring side branches and where Q is not H.
  • In an alternative aspect the inventive compounds are embraced by structure III
  • Figure US20100210788A1-20100819-C00012
  • where X is an electron withdrawing group (such as CN, CO2R, CO2H, COCl, COR, COPO(OR)2, COPOR2, SO2R, SO3R or NO2, where R is C1-4) or F, D is selected from H, alkyl or aryl, Z is a reactive functionality, n is 0 or 1 and g is 1. The reactive functionality of Z in structure III may be selected from epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, succinimides, 2-cyanoacrylates, methylidene malonates, acrylonitrile, (meth)acrylates, carboxylic acids and derivatives thereof, cyanoacetates, methylene malonates, hydroxyls, silanes, siloxanes, titanates, or zirconates.
  • Representative examples of novel electron deficient olefins within the scope of the invention include
  • Figure US20100210788A1-20100819-C00013
  • To prepare such compounds in accordance with the present invention, one may use imines embraced by structure VI or iminium salts embraced by structure VII.
  • The imine embraced within structure VI is as follows:
  • Figure US20100210788A1-20100819-C00014
  • where K is
  • Figure US20100210788A1-20100819-C00015
    • where in this connection R1-R2 are each independently selected from hydrogen, alkenyl, or alkynyl; and A-B are each independently selected from linear, branched, or cyclic alkyl or alkenyl which may be interrupted with heteroatoms or substituted by functional groups, or A and B taken together form a cyclic or polycyclic alkyl or alkenyl structure, which may be interrupted with heteroatoms or substituted by functional groups;
    • E is selected from a linear, branched or cyclic hydrocarbon with or without one or more nitrogen-containing substituents thereon, a heterocyclic, an aromatic or an organosiloxane group or part thereof or linkage; and
    • R3 in this connection is selected from a hydrocarbon, a heterocyclic, an aromatic or an organosiloxane group or linkage;
    • w is 1-100; y is 1-100 and z is 0-100.
      When more than one of K, E or R3 are present, each instance thereof is defined independently from the other instance(s).
  • The imine more specifically is embraced within structure VIA as follows:
  • Figure US20100210788A1-20100819-C00016
  • where in this connection R1-R2, A-B, E, R3, w, y and z are as defined above.
  • The iminium salt embraced within structure VII is as follows:
  • Figure US20100210788A1-20100819-C00017
  • where K is
  • Figure US20100210788A1-20100819-C00018
    • where in this connection R1-R2 are each independently selected from hydrogen, alkenyl, or alkynyl; and A-B are each independently selected from linear, branched, or cyclic alkyl or alkenyl which may be interrupted with heteroatoms or substituted by functional groups, or A and B taken together form a cyclic or polycyclic alkyl or alkenyl structure, which may be interrupted with heteroatoms or substituted by functional groups;
    • E is selected from a linear, branched or cyclic hydrocarbon with or without one or more nitrogen-containing substituents thereon, a heterocyclic, an aromatic or an organosiloxane group or part thereof or linkage; and
    • R3 in this connection is selected from a hydrocarbon, a heterocyclic, an aromatic or an organosiloxane group or linkage;
    • w is 1-100; y is 1-100 and z is 0-100; and
    • X is an anion.
      When more than one of K, E or R3 are present, each instance thereof is defined independently from the other instance(s).
  • The iminium salt is embraced more specifically by structure VIIA as follows:
  • Figure US20100210788A1-20100819-C00019
  • where in this connection R1-R2, A-B, E, R3, w, y and z, and X are as defined above.
  • The imine in some cases may be an imine having an onium salt, such as an ammonium or amine salt functionality. In some cases the imines may be termed an “ionic liquid” (or “IL”) or a task specific ionic liquid (or, “TSIL”), as will be discussed in more detail below. Likewise, the iminium salts may be termed an “ionic liquid” (or “IL”) or a task specific ionic liquid (or, “TSIL”), as will be discussed in more detail below.
  • In such cases where the imine of structure VI or the iminium salt of structure VII is particularly stable at room temperature conditions when in the presence of the precursor to the electron deficient olefin, a modest amount of heat may be useful to allow the reaction to generate electron deficient olefins. Exposure to elevated temperature conditions is particularly desirable with iminium salts of structure VII.
  • Reference to the figures may be useful to appreciate further how electron deficient olefins of the present invention are prepared, which is described in more detail below and in the Examples section that follows thereafter.
  • Thus, as an initial reactant, is an aldehyde compound having the structure R3R4C═O, where R3 is hydrogen and R4 is a hydrogen, vinyl or propargyl. The aldehyde compound may be an aldehyde itself or a source of an aldehyde, such as one that yields an aldehyde like formaldehyde under appropriate reaction conditions. The aldehyde compound in a desirable embodiment includes formaldehyde or a source thereof, such as paraformaldehyde (see FIG. 1), formalin, or 1,3,5-trioxane, or vinyl aldehydes, such as acrolein.
  • As a reactant with such an aldehyde is a primary amine. Primary amines attached to a carbon bearing no alpha protons are particularly desirable, such as t-alkyl primary amines. Rohm and Haas Co., Philadelphia, Pa. has sold commercially for a number of years a series of t-alkyl primary amines, which are designated as PRIMENE-brand amines.
  • For instance, t-alkyl primary amines available from Rohm and Haas include PRIMENE 81-R and PRIMENE JM-T. These PRIMENE-brand t-alkyl primary amines have highly branched alkyl chains (represented schematically by circle symbols in the Figures for simplicity) in which the amino nitrogen atom is attached directly to a tertiary carbon. These t-alkyl primary amines consist of mixtures of isomeric amines, with PRIMENE 81-R consisting of an isomeric mixture with C12-C14 carbon branches and having an average molecular weight of 185 and PRIMENE JM-T consisting of an isomeric mixture with C16-C22 carbon branches and having average molecular weight of 269.
  • PRIMENE MD, also known as menthanediamine (1,8-diamino-p-menthane) or (4-amino-α,α-4-trimethyl-cyclohexanemethanamine, CAS No. 80-52-4), is a primary alicyclic diamine, in which both amino groups are attached to tertiary carbon atoms. Like other alicyclic t-alkyl primary amines, menthanediamine is somewhat less reactive than similar straight chain diamines. Yet another PRIMENE, PRIMENE TOA has tertiary octyl chains and a molecular weight of 129. In the examples given below, PRIMENE 81-R MSA iminium salt, formed in reaction (2) of FIG. 1, is used.
  • The imines, whether or not bearing ammonium salt functionality or whether or not they are tethered to a support, are then reacted with compounds containing a methylene linkage having at least one, desirably two, electron withdrawing substituent(s) attached thereto. The preparation of a methylene compound useful as a precursor to an electron deficient olefin is depicted in FIG. 2, which illustrates the esterification of cyanoacetic acid with alpha hydroxymethyl acrylate. In these compounds, the electron withdrawing substituent is selected from nitrile, carboxylic acids, carboxylic esters, sulphonic or suphinic acids or their esters, ketones, phosphocarbonyl, or nitro. Such compounds are reacted with iminium salts for example as depicted in FIG. 3 to form novel electron deficient olefins. In a desirable embodiment, these compounds have two or more electron withdrawing substituents, which may be the same or different, such as nitrile and carboxylic acid ester—in this case, a cyanoacrylate. Of course, the reactivity of these compounds in large part depends on the degree of electron withdrawing capability of the particular substituent, and the number of substituents on the active methylene carbon.
  • The reaction to form the novel electron deficient olefins may proceed with or without heating or cooling, depending of course on the specific reactants and the scale of the reaction. Decomposition of the source of formaldehyde, e.g., paraformaldehyde, may occur under gentle heating up to a temperature of about 70° C., to liberate formaldehyde in situ in the reaction medium. The temperature may be reached through an external heating element or internally by means of the exotherm that may be generated, depending of course on the identity of the reactants. The temperature of the reaction should be controlled however to accommodate any such exothermic processes.
  • The time of reaction may be monitored by reference to the formation of the desired novel electron deficient olefin product. A 1H NMR spectrometer is a particularly useful tool in this regard. The time of reaction may be as little as 1 minute, for instance, or longer or shorter for that matter depending again on the identity of the specific, reactants, the scale of the reaction and whether heat is introduced to or removed from the reaction conditions.
  • Once formed, the novel electron deficient olefin may be isolated by direct distillation under vacuum out of the reaction mixture or by freezing it in a solid form and separating off the liquid phase.
  • The novel electron deficient olefin may be stabilized during the synthesis and/or isolation procedure, and also in the isolated product to improve its shelf life. Suitable stabilizers include stabilizer packages that may contain one or more of free radical stabilizers and acidic stabilizers.
  • For example, free radical stabilizers include hydroquinone, pyrocatechol, resorcinol or derivatives thereof, such as hydroquinone monoethyl ether, or phenols, such as di-t-butylphenol or 2,6-di-t-butyl-p-cresol, 2,2′-methylene-bis-(4-methyl-6-t-butylphenol), bisphenol A, dihydroxydiphenylmethane, and styrenized phenols.
  • For example, acidic stabilizers include sulfuric acid, hydrochloric acid, sulfonic acids, such as methane, ethane or higher sulfonic acids, p-toluene sulfonic acid, phosphoric acid or polyphosphoric acids, silyl esters of strong acids, such as trialkyl chlorosilanes, dialkyl dichlorosilanes, alkyl trichlorosilanes, tetrachlorosilane, trialkyl silylsulfonic acids, trialkyl silyl-p-toluene sulfonates, bis-trialkyl silylsulfate and trialkyl silylphosphoric acid esters.
  • The amount of either stabilizer used to stabilize the electron deficient olefin prepared by the inventive processes is well known to those of ordinary skill in the art, and may be varied depending on the properties of the resulting composition made from the so formed electron deficient olefin.
  • The present invention also provides compositions of the compounds of structures I, II or III, together with a stabilizer package comprising at least one of a free radical stabilizer and an anionic stabilizer; and optionally, one or more additives selected from cure accelerators, thickeners, thixotropes, tougheners, thermal resistance-conferring agents, or plasticizers.
  • The cure accelerators that may be included with the inventive electron deficient olefins to form inventive compositions include calixarenes and oxacalixarenes, silacrowns, crown ethers, cyclodextrins, poly(ethyleneglycol) di(meth)acrylates, ethoxylated hydric compounds and combinations thereof.
  • Of the calixarenes and oxacalixarenes, many are known, and are reported in the patent literature. See e.g. U.S. Pat. Nos. 4,556,700, 4,622,414, 4,636,539, 4,695,615, 4,718,966, and 4,855,461, the disclosures of each of which are hereby expressly incorporated herein by reference.
  • For instance, as regards calixarenes, those within the following structure are useful herein:
  • Figure US20100210788A1-20100819-C00020
  • where in this connection R1 is alkyl, alkoxy, substituted alkyl or substituted alkoxy; R2 is H or alkyl; and n is 4, 6 or 8.
  • One particularly desirable calixarene is tetrabutyl tetra[2-ethoxy-2-oxoethoxy]calix-4-arene.
  • A host of crown ethers are known. For instance, examples which may be used herein include 15-crown-5,18-crown-6, dibenzo-18-crown-6, benzo-15-crown-5-dibenzo-24-crown-8, dibenzo-30-crown-10, tribenzo-18-crown-6, asym-dibenzo-22-crown-6, dibenzo-14-crown-4, dicyclohexyl-18-crown-6, dicyclohexyl-24-crown-8, cyclohexyl-12-crown-4, 1,2-decalyl-15-crown-5,1,2-naphtho-15-crown-5,3,4,5-naphtyl-16-crown-5,1,2-methyl-benzo-18-crown-6,1,2-methylbenzo-5,6-methylbenzo-18-crown-6,1,2-t-butyl-18-crown-6,1,2-vinylbenzo-15-crown-5,1,2-vinylbenzo-18-crown-6,1,2-t-butyl-cyclohexyl-18-crown-6, asym-dibenzo-22-crown-6 and 1,2-benzo-1,4-benzo-5-oxygen-20-crown-7. See U.S. Pat. No. 4,837,260 (Sato), the disclosure of which is hereby expressly incorporated here by reference.
  • Of the silacrowns, again many are known, and are reported in the literature. For instance, a typical silacrown may be represented within the following structure:
  • Figure US20100210788A1-20100819-C00021
  • where in this connection R3 and R4 are organo groups which do not themselves cause polymerization of the cyanoacrylate monomer, R5 is H or CH3 and n is an integer of between 1 and 4. Examples of suitable R3 and R4 groups are R groups, alkoxy groups, such as methoxy, and aryloxy groups, such as phenoxy. The R3 and R4 groups may contain halogen or other substituents, an example being trifluoropropyl. However, groups not suitable as R4 and R5 groups are basic groups, such as amino, substituted amino and alkylamino.
  • Specific examples of silacrown compounds useful in the inventive compositions include:
  • Figure US20100210788A1-20100819-C00022
  • dimethylsila-11-crown-4;
  • Figure US20100210788A1-20100819-C00023
  • dimethylsila-14-crown-5;
  • Figure US20100210788A1-20100819-C00024
  • and dimethylsila-17-crown-6.
    See e.g. U.S. Pat. No. 4,906,317 (Liu), the disclosure of which is hereby expressly incorporated herein by reference.
  • Many cyclodextrins may be used in connection with the present invention. For instance, those described and claimed in U.S. Pat. No. 5,312,864 (Wenz), the disclosure of which is hereby expressly incorporated herein by reference, as hydroxyl group derivatives of an α-, β- or γ-cyclodextrin which is at least partly soluble in the cyanoacrylate would be appropriate choices for use herein as the first accelerator component.
  • For instance, poly(ethylene glycol) di(meth)acrylates suitable for use herein include those within the following structure:
  • Figure US20100210788A1-20100819-C00025
  • where n is greater than 3, such as within the range of 3 to 12, with n being 9 as particularly desirable. More specific examples include PEG 200 DMA (where n is about 4), PEG 400 DMA (where n is about 9), PEG 600 DMA (where n is about 14), and PEG 800 DMA (where n is about 19), where the number (e.g., 400) represents the average molecular weight of the glycol portion of the molecule, excluding the two methacrylate groups, expressed as grams/mole (i.e., 400 g/mol). A particularly desirable PEG DMA is PEG 400 DMA.
  • And of the ethoxylated hydric compounds (or ethoxylated fatty alcohols that may be employed), appropriate ones may be chosen from those within the following structure:
  • Figure US20100210788A1-20100819-C00026
  • where Cm can be a linear or branched alkyl or alkenyl chain, m is an integer between 1 to 30, such as from 5 to 20, n is an integer between 2 to 30, such as from 5 to 15, and R in this connection may be H or alkyl, such as C1-6 alkyl.
  • Commercially available examples of materials within the above structure include those offered under the DEHYDOL tradename from Henkel KGaA, Dusseldorf, Germany, such as DEHYDOL 100.
  • When used, the cure accelerator should be included in the compositions in an amount within the range of from about 0.01% to about 10% by weight, with the range of about 0.1 to about 0.5% by weight being desirable, and about 0.4% by weight of the total composition being particularly desirable.
  • Other additives may be included with the inventive electron deficient olefins to form inventive compositions to confer additional physical properties, such as improved shock resistance, thickness (for instance, polymethyl methacrylate), thixotropy (for instance fumed silica), color, and enhanced resistance to thermal degradation [for instance, maleimide compounds such as N,N′-meta-phenylene bismaleimide (see U.S. Pat. No. 3,988,299 (Malofsky)), certain mono, poly or hetero aromatic compounds characterized by at least three substitutions on an aromatic ring thereof, two or more of which being electron withdrawing groups (see U.S. Pat. No. 5,288,794 (Attarwala)), certain quinoid compounds (see U.S. Pat. No. 5,306,752 (Attarwala)), certain sulfur-containing compounds, such as an anhydrosulfite, a sulfoxide, a sulfite, a sulfonate, a methanesulfonate or a p-toluenesulfonate (see U.S. Pat. No. 5,328,944 (Attarwala)), or certain sulfur-containing compounds, such as a sulfinate, a cyclic sultinate naphthosultone compound substituted with at least one strong electron withdrawing group at least as strongly electron withdrawing as nitro (see U.S. Pat. No. 5,424,343 (Attarwala)), and alkylating agents such as polyvinyl benzyl chloride, 4-nitrobenzyl chloride, and combinations thereof, silylating agents, and combinations thereof (see U.S. Pat. No. 6,093,780 (Attarwala)), the disclosures of each of which are hereby incorporated herein by reference. Such additives therefore may be selected from certain acidic materials (like citric acid), thixotropy or gelling agents, thickeners, dyes, thermal degradation resistance enhancers, and combinations thereof. See e.g. U.S. patent application Ser. No. 11/119,703 and U.S. Pat. Nos. 5,306,752, 5,424,344 and 6,835,789, the disclosures of each of which are hereby incorporated herein by reference.
  • These other additives may be used in the inventive compositions individually in an amount from about 0.05% to about 20%, such as about 1% to 15%, desirably 5% to 10% by weight, depending of course on the identity of the additive. For instance, and more specifically, citric acid may be used in the inventive compositions in an amount of 5 to 500 ppm, desirably 10 to 100 ppm.
  • Of course, the molecular design of the inventive electron deficient olefins may render it less desirable to include one or more these additives with the inventive electron deficient olefins to form inventive compositions.
  • The present invention further provides compositions of the inventive compounds, together with a cyanoacrylate, a methylidene malonate or combinations thereof.
  • More specifically, the cyanoacrylate used in combination with the inventive compounds is one within structure IV:
  • Figure US20100210788A1-20100819-C00027
  • where in this connection R1 is selected from C1-16 alkyl, alkoxyalkyl, cycloalkyl, alkenyl (such as allyl), alkynyl, arylalkyl, aryl, or haloalkyl groups.
  • The cyanoacrylate with structure IV is selected from methyl cyanoacrylate, ethyl-2-cyanoacrylate, propyl cyanoacrylates, butyl cyanoacrylates, octyl cyanoacrylates, allyl cyanoacrylate, β-methoxyethyl cyanoacrylate and combinations thereof.
  • The methylidene malonate used in combination with the inventive compounds is one within structure V:
  • Figure US20100210788A1-20100819-C00028
  • where in this connection R2 and R3 are each independently selected from C1-16 alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl or haloalkyl groups.
  • The present invention further provides compositions of certain of the compounds of structure I, together with a coreactant, such as one selected from epoxides (such as cycloaliphatic epoxies), episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, (meth)acrylates, acrylamides, cyanoacrylates, methylidene malonates or vinyl ethers. Particularly desirable compounds within structure I for this purpose include
  • Figure US20100210788A1-20100819-C00029
  • The following examples are intended to illustrate but in no way limit the present invention.
  • Examples Example 1
  • PRIMENE 81-R imine was prepared by reaction of PRIMENE 81-R amine with a stoichiometric equivalent of paraformaldehyde and removal of water of condensation. All imines formed were distillable liquids and existed in stable monomeric imine forms as confirmed by 1H NMR 60 MHz (CDCl3) 2H s (br) 7.45 ppm and FTIR (1650 cm−1).
  • Example 2
  • PRIMENE 81-R iminium-MSA was prepared from PRIMENE 81-R imine by adding dropwise with stirring methane sulfonic acid at ice water bath temperature, yielding a pale yellow iminium salt.
  • Example 3
  • Figure US20100210788A1-20100819-C00030
  • To a stirring mixture of cyanoacetic acid (90 g, 1.05 mol), ethyl 2-hydroxylmethyl acrylate (130 g, 1.0 mol), p-toluene sulfonic acid (500 mg) and hydroquinone (200 mg), was added toluene (150 mL), and the mixture was refluxed at a temperature of 150° C. to azeotropically remove water.
  • After cooling, the reaction product was washed consecutively with 30% brine and water. The organic layer was dried over anhydrous sodium sulfate, filtered and the solvent removed by rotary evaporator. The crude reaction product was purified by vacuum distillation (120-126° C./0.2 mbar), with the ester of structure A (102 g, 0.52 mol) isolated in a 52% yield. 1H NMR (60 MHz, CDCl3): δ 6.39 (s, 1H), 5.89 (s, 1H), 4.90 (s, 2H), 4.28 (q, J=6.0 Hz, 2H), 3.50 (s, 2H), 1.32 (t, J=6.0 Hz, 3H); FT-IR (film): 2983.3, 2935.3, 2264.3, 1753.6, 1719.7, 1640.0, 1448.3, 1368.2, 1310.3, 1177.0, 1027.1, 817.2 cm−1; GC/MS (EI) m/z (%): 198 (2) [M++H], 152 (40), 129 (25), 101 (38), 85 (100), 83 (45), 68 (80).
  • Example 4
  • Figure US20100210788A1-20100819-C00031
  • To a stirring solution of 2-hydroxymethylacrylonitrile (21 g, 0.25 mole) and cyanoacetic acid (20.5 g, 0.24 mole) in dry THF (0.5 l), was added a solution of dicarbodiimide (“DCC”) (51.6 g, 0.25 mole) in dry THF (100 mL) over a period of time of 30 minutes at a temperature of 0° C. The reaction mixture was stirred overnight at room temperature and the solid material that formed was filtered off and washed with dry THF. The THF was removed in vacuo, the residue dissolved in dichloromethane and the solution passed through a pad of flash silica gel (200 g). The product obtained was purified additionally by precipitation with diethyl ether from its solution in dichloromethane furnishing 30.5 grams of the ester, B in a 81% yield. 1H NMR (250 MHz, CDCl3): δ 3.58 (s, 2H), 4.80 (m, 2H), 6.13 (m, 1H), 6.19 (m, 1H); 13C NMR (62.9 MHz, CDCl3): δ 24.4, 64.7, 112.6, 116.0, 116.8, 135.0, 162.4.
  • Example 5
  • Figure US20100210788A1-20100819-C00032
  • To a stirring mixture of monoethyl malonate (5.1 g, 38.6 mmol), ethyl 2-hydroxylmethyl acrylate (5.02 g, 3.86 mmol), PTSA (50 mg) and hydroquinone (50 mg), was added toluene (50 mL) and the mixture was refluxed at a temperature of 150° C. to azeotropically remove water.
  • After cooling, the reaction product was washed consecutively with 30% brine and water, and the organic layer was dried over anhydrous sodium sulfate, filtered and the solvent removed by rotary evaporator. The crude reaction product was purified by vacuum distillation (98-100° C./0.1 mbar) and the ester, C was isolated in 80% yield. 1H NMR (60 MHz, CDCl3): δ 6.36 (s, 1H), 5.87 (s, 1H), 4.89 (s, 2H), 4.05-4.41 (m, 4H), 3.43 (s, 2H), 1.19-1.42 (m, 6H); FT-IR (film): 2984.7, 2908.6, 1735.3 (br), 1640.5, 1513,6, 1447.6, 1332.2, 1145.4, 1031.7, 817.2 cm−1; GC/MS (EI) m/z (%): 245 (2) [M++H], 226 (2), 199 (20), 153 (20), 129 (70), 115 (100), 101 (40), 85 (45), 43 (65).
  • Example 6
  • Figure US20100210788A1-20100819-C00033
  • To a stirring mixture of monoethyl malonate (10.18 g, 77 mmol), ethyl 2-hydroxylmethyl acrylonitrile (7.67 g, 92 mmol), conc. H2SO4 (3 drops) and hydroquinone (1.0 g), was added toluene (50 mL) and the mixture was refluxed at a temperature of 150° C. to azeotropically remove water.
  • After cooling, the reaction product was washed consecutively with 30% brine and water, and the organic layer was dried over anhydrous sodium sulfate, filtered and the solvent removed by rotary evaporator. The crude reaction product was purified by vacuum distillation (86-88° C./0.05 mbar) and 7.5 g, 38 mmol of the ester, D was isolated in 49% yield. 1H NMR (60 MHz, CDCl3): δ 6.10 (s, 2H), 4.75 (s, 2H), 4.20 (q, J=6.6 Hz, 2H), 3.47 (s, 2H), 1.34 (t, J=6.6 Hz, 3H); FT-IR (film): 3118.1, 2986.9, 2909.0, 2230.0, 1736.0, 1629.3, 1447.3, 1371.1, 1147.8, 1033.0, 959.6 cm−1; GC/MS (EI) m/z (%) : 197 (2) [M+], 170 (40), 152 (100), 125 (10), 115 (50), 107 (15), 87 (25), 79 (45), 66 (90), 53 (40), 43 (60).
  • Example 7
  • Figure US20100210788A1-20100819-C00034
  • To a stirring mixture of PRIMENE 81-R iminium-MSA (5.86 g, 20 mmol) and cyanoacetate, A (g, 20 mmol), was added 10 mg of hydroquinone and degassed for a period of time of 5 minutes at room temperature. Immediately thereafter, the degassed stirring mixture was vacuum distilled (0.2 mbar) at a temperature of 200° C. The cyanoacrylate ester, E was collected as a colourless oil (60% purity by GC, 36% yield). 1H NMR (60 MHz, CDCl3): δ 7.01 (s, 1H), 6.58 (s, 1H), 6.36 (s, 1H), 5.88 (s, 1H), 4.95 (s, 1H), 4.27 (q, J=6.6 Hz, 2H), 1.30 (t, J=6.6 Hz, 3H); FT-IR (film): 3125.4 (C═C), 2937.7, 2875.0, 2238.3 (CN), 1723.8 (b, s, CO), 1641.6 (C═C), 1389.2, 1310.6, 1155.5, 1026.7, 803.6 cm−1.
  • Example 8
  • Figure US20100210788A1-20100819-C00035
  • To a stirring mixture of PRIMENE 81-R iminium-MSA (2.93 g, 10 mmol) and the triester, C (2.44 g, 10 mmol), was added 10 mg of hydroquinone and degassed for a period of time of 5 minutes at room temperature. Immediately thereafter, the degassed stirring mixture was vacuum distilled (0.1 mbar) at a temperature of 200° C. The triester, F was collected as a colourless oil (1.7 g, 110-120° C./0.1 mbar, 43% purity by GC, 28% yield). GC/MS shows the sample is a mixture of monomer and acetate (1:1.3); 1H NMR (60 MHz, CDCl3): δ 6.51 (s, 1H), 6.34 (s, 2H), 5.86 (s, 1H), 4.94 (s, 1H), 4.39-4.04 (m, 4H), 1.42-1.18 (m, 6H); FT-IR (film): 2984.0, 2908.7, 1731.5, 1640.6, 1400.5, 1330.5, 1272.1, 1191.5, 1144.1, 1029.3, 813.1 cm−1.
  • Example 9
  • Figure US20100210788A1-20100819-C00036
  • To a stirring mixture of PRIMENE 81-R iminium-MSA (2.93 g, 10 mmol) and the diester nitrile, D (1.97 g, 10 mmol), was added 10 mg of hydroquinone and degassed for a period of time of 5 minutes at room temperature. Immediately thereafter, the degassed stirring mixture was vacuum distilled (0.1 mbar) at a temperature of 200° C. The diester nitrile, G was collected as a colourless oil (1.7 g, 94-104° C./0.25-0.35 mbar, 80% purity by GC, 65% yield). 1H NMR (60 MHz, CDCl3): δ 6.62 (s, 2H), 6.12 (s, 2H), 4.81 (s, 2H), 4.26 (q, J=6.0 Hz, 2H), 1.33 (t, J=6.0 Hz, 3H); FT-IR (film): 3118.4, 2985.8, 2229.9, 1736.1, 1628.7, 1407.3, 1371.9, 1331.0, 1191.8, 1030.2, 805.9 cm−1.
  • Example 10
  • Figure US20100210788A1-20100819-C00037
  • To a stirring mixture of PRIMENE 81-R iminium-MSA (2.93 g, 10 mmol) and the dinitrile ester, B (1.50 g, 10 mmol), was added 10 mg of hydroquinone and degassed for a period of time of 5 minutes at room temperature. Immediately thereafter, the degassed stirring mixture was vacuum distilled (0.2 mbar) at a temperature of 200° C. The dinitrile ester, K was collected as a colourless oil (0.96 g, 140-160° C./0.2-0.3 mbar, 43% purity by NMR, 25% yield). The sample was determined to contain 2-hydroxylmethyl acrylonitrile. 1H NMR (60 MHz, CDCl3): δ 7.04 (s, 1H), 6.64 (s, 1H), 6.12 (s, 2H), 4.82 (s, 2H); FT-IR (film): 3124.9, 2960.9, 2874.6, 2229.5, 1745.0, 1678.1, 1528.9, 1284.3, 1177.4, 955.0, 802.5 cm−1.
  • The table below shows the starting intermediate, the resulting electron deficient olefin, the purity of the resulting electron deficient olefin and the yield in which some of the electron deficient olefins described above were obtained.
  • TABLE 1
    Electron Deficient Purity Yield
    Intermediate Olefin by GC (%) (%)
    Figure US20100210788A1-20100819-C00038
    Figure US20100210788A1-20100819-C00039
    60 36
    Figure US20100210788A1-20100819-C00040
    Figure US20100210788A1-20100819-C00041
    43 28
    Figure US20100210788A1-20100819-C00042
    Figure US20100210788A1-20100819-C00043
    80 65
    Figure US20100210788A1-20100819-C00044
    Figure US20100210788A1-20100819-C00045
    43 25

Claims (17)

1. Compounds embraced by structure I
Figure US20100210788A1-20100819-C00046
wherein X is (a) an electron withdrawing group, or (b) Y;
Y is
Figure US20100210788A1-20100819-C00047
wherein D is a member selected from the group consisting of H, alkyl and aryl,
Z is either
(i)
Figure US20100210788A1-20100819-C00048
wherein Q is
a. an electron withdrawing group or
b. a first reactive functionality, or
(ii) a second reactive functionality, g is 1-10; and
n is 0 or 1.
2. Compounds according to claim 1, wherein X is an electron withdrawing group selected from the group consisting of CN, CO2R, CO2H, COCl, COR, COPO(OR)2, COPOR2, SO2R, SO3R and NO2, wherein R is C1-4.
3. Compounds according to claim 1, wherein Y is
Figure US20100210788A1-20100819-C00049
wherein D is a member selected from the group consisting of H, alkyl and aryl, Z is
Figure US20100210788A1-20100819-C00050
wherein Q is an electron withdrawing group selected from the group consisting of CN, CO2R, CO2H, COCl, COR, COPO(OR)2, COPOR2, SO2R, SO3R and NO2, wherein R is C1-4, and g is 1.
4. Compounds according to claim 1, wherein Y is
Figure US20100210788A1-20100819-C00051
wherein D is a member selected from the group consisting of H, alkyl and aryl, Z is
Figure US20100210788A1-20100819-C00052
wherein Q is a first reactive functionality selected from the group consisting of amides and thioamides and g is 1.
5. Compounds according to claim 1, wherein Y is
Figure US20100210788A1-20100819-C00053
wherein D is a member selected from the group consisting of H, alkyl and aryl, Z is a second reactive functionality selected from the group consisting of epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, succinimides, 2-cyanoacrylates, methylidene malonates, acrylonitrile, (meth)acrylates, carboxylic acids and derivatives thereof, cyanoacetates, methylene malonates, hydroxyls, silanes, siloxanes, titanates, and zirconates, and g is 1.
6. Compounds according to claim 1, embraced by structure II
Figure US20100210788A1-20100819-C00054
wherein X is an electron withdrawing group or E, E is as shown,
Figure US20100210788A1-20100819-C00055
is a reactive functionality, D is a member selected from the group consisting of H, alkyl and aryl, n is 0 or 1, g is 1, and A, B, 1, 2, 3, 4, 5, and 6 are each references to bond designations.
7. Compounds according to claim 1, embraced by structure III
Figure US20100210788A1-20100819-C00056
wherein X is an electron withdrawing group or F, D is a member selected from the group consisting of H, alkyl and aryl, Z is a reactive functionality, n is 0 or 1 and g is 1.
8. Compounds according to claim 7, wherein Z is a second reactive, functionality selected from the group consisting of epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, succinimides, 2-cyanoacrylates, methylidene malonates, acrylonitrile, (meth)acrylates, carboxylic acids and derivatives thereof, cyanoacetates, methylene malonates, hydroxyls, silanes, siloxanes, titanates, and zirconates.
9. Compounds according to claim 1, selected from the group consisting of
Figure US20100210788A1-20100819-C00057
10. A composition comprising:
(a) one or more compounds of claim 1;
(b) a stabilizer package comprising at least one of a free radical stabilizer and an anionic stabilizer; and
(c) optionally, one or more additives selected from the group consisting of cure accelerators, thickeners, thixotropes, tougheners, thermal resistance-conferring agents, and plasticizers.
11. The composition of claim 10, further comprising a cyanoacrylate within structure IV:
Figure US20100210788A1-20100819-C00058
wherein R1 is selected from C1-16 alkyl, alkoxyalkyl, cycloalkyl, alkenyl, alkynyl, arylalkyl, aryl, allyl and haloalkyl groups.
12. The composition of claim 11, wherein the cyanoacrylate is selected from methyl cyanoacrylate, ethyl-2-cyanoacrylate, propyl cyanoacrylates, butyl cyanoacrylates, octyl cyanoacrylates, allyl cyanoacrylate, β-methoxyethyl cyanoacrylate and combinations thereof.
13. The composition of claim 10, further comprising a methylidene malonate within structure V:
Figure US20100210788A1-20100819-C00059
wherein R2 and R3 are each independently selected from C1-16 alkyl, alkoxyalkyl, cycloalkyl, alkenyl, alkynyl, arylalkyl, aryl, allyl and haloalkyl groups.
14. A composition comprising:
(a) one or more compounds of claim 9;
(b) a stabilizer package comprising at least one of a free radical stabilizer and an anionic stabilizer; and
(c) optionally, one or more additives selected from the group consisting of cure accelerators, thickeners, thixotropes, tougheners, thermal resistance-conferring agents, and plasticizers.
15. The composition of claim 14, further comprising a coreactant.
16. The composition of claim 15, wherein the coreactant is a member selected from the group consisting of epoxides, episulfides, oxetanes, thioxetanes, dioxolanes, dioxanes, isocyanates, maleimides, oxazolines, (meth)acrylates, acrylamides, cyanoacrylates, methylidene malonates, and vinyl ethers.
17. Compounds according to claim 4, wherein the amides or thioamides of Q are embraced by

C(T)NUV,
wherein T is O or S and U or V are each independently selected from H or R, wherein R is C1-4.
US12/766,457 2007-10-24 2010-04-23 Electron deficient olefins Abandoned US20100210788A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/766,457 US20100210788A1 (en) 2007-10-24 2010-04-23 Electron deficient olefins
US14/663,722 US20150191424A1 (en) 2007-10-24 2015-03-20 Electron deficient olefins
US14/945,843 US9481640B2 (en) 2007-10-24 2015-11-19 Electron deficient olefins

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98215707P 2007-10-24 2007-10-24
PCT/EP2008/064490 WO2009053484A2 (en) 2007-10-24 2008-10-24 Electron deficient olefins and curable compositions prepared therefrom
US12/766,457 US20100210788A1 (en) 2007-10-24 2010-04-23 Electron deficient olefins

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/064490 Continuation WO2009053484A2 (en) 2007-10-24 2008-10-24 Electron deficient olefins and curable compositions prepared therefrom

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/663,722 Continuation US20150191424A1 (en) 2007-10-24 2015-03-20 Electron deficient olefins

Publications (1)

Publication Number Publication Date
US20100210788A1 true US20100210788A1 (en) 2010-08-19

Family

ID=40347783

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/766,457 Abandoned US20100210788A1 (en) 2007-10-24 2010-04-23 Electron deficient olefins
US14/663,722 Abandoned US20150191424A1 (en) 2007-10-24 2015-03-20 Electron deficient olefins
US14/945,843 Active US9481640B2 (en) 2007-10-24 2015-11-19 Electron deficient olefins

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/663,722 Abandoned US20150191424A1 (en) 2007-10-24 2015-03-20 Electron deficient olefins
US14/945,843 Active US9481640B2 (en) 2007-10-24 2015-11-19 Electron deficient olefins

Country Status (8)

Country Link
US (3) US20100210788A1 (en)
EP (1) EP2217559B1 (en)
JP (1) JP5639892B2 (en)
KR (1) KR101571913B1 (en)
CN (1) CN102083784A (en)
CA (1) CA2703603A1 (en)
ES (1) ES2634631T3 (en)
WO (1) WO2009053484A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113035A1 (en) 2012-01-28 2013-08-01 Optmed, Inc. Improved methylidene malonate process
TWI511943B (en) * 2014-03-31 2015-12-11 Afinitica Technologies S L Process for preparing 1,1-disubstituted ethylene monomers
US10196471B1 (en) * 2008-10-24 2019-02-05 Henkel IP & Holding GmbH Curable composition having an electron deficient olefin
WO2021150844A1 (en) 2020-01-24 2021-07-29 Sirrus, Inc. Compositions containing 1,1-disubstituted activated alkenes useful in additive manufacturing and articles formed therefrom

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10414839B2 (en) 2010-10-20 2019-09-17 Sirrus, Inc. Polymers including a methylene beta-ketoester and products formed therefrom
US9249265B1 (en) 2014-09-08 2016-02-02 Sirrus, Inc. Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
US9828324B2 (en) 2010-10-20 2017-11-28 Sirrus, Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
EP3153530B1 (en) 2012-03-30 2021-02-24 Sirrus, Inc. Composite and laminate articles and polymerizable systems for producing the same
WO2013181600A2 (en) 2012-06-01 2013-12-05 Bioformix Inc. Optical material and articles formed therefrom
EP2920231B1 (en) 2012-11-16 2020-05-06 Sirrus, Inc. Plastics bonding systems and methods
CN105164797B (en) 2012-11-30 2019-04-19 瑟拉斯公司 Complex composition for electronic application
US9416091B1 (en) 2015-02-04 2016-08-16 Sirrus, Inc. Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9315597B2 (en) 2014-09-08 2016-04-19 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US10501400B2 (en) 2015-02-04 2019-12-10 Sirrus, Inc. Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9334430B1 (en) 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
JP6974342B2 (en) * 2016-03-01 2021-12-01 ヘンケル アイピー アンド ホールディング ゲゼルシャフト ミット ベシュレンクテル ハフツング Photocurable electron deficiency olefin-containing composition
US9617377B1 (en) 2016-06-03 2017-04-11 Sirrus, Inc. Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US9567475B1 (en) 2016-06-03 2017-02-14 Sirrus, Inc. Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10196481B2 (en) 2016-06-03 2019-02-05 Sirrus, Inc. Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof
US10428177B2 (en) 2016-06-03 2019-10-01 Sirrus, Inc. Water absorbing or water soluble polymers, intermediate compounds, and methods thereof

Citations (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2363464A (en) * 1942-04-29 1944-11-21 Commercial Solvents Corp Beta-aminoalkyl acetals
US2413249A (en) * 1945-05-07 1946-12-24 Commercial Solvents Corp 1,5-bis-(1-nitro-3,5-dioxacyclohexyl)-2,4 dioxapentane
US2413250A (en) * 1945-05-07 1946-12-24 Commercial Solvents Corp 1,5-bis (1-amino-3,5-dioxacyclohexyl) 2,4 dioxapentane
US2415046A (en) * 1944-04-21 1947-01-28 Commercial Solvents Corp Acetals of nitro alcohols
US2582128A (en) * 1950-02-11 1952-01-08 Rohm & Haas Aldimines
US2721858A (en) * 1954-03-10 1955-10-25 Eastman Kodak Co Method of making alpha-cyanoacrylates
US2756251A (en) * 1954-03-23 1956-07-24 Eastman Kodak Co Preparation of monomeric alpha-cyanoacrylates
US2763677A (en) * 1954-12-20 1956-09-18 Eastman Kodak Co Process for making monomeric alpha-cyanoacrylates
US2870193A (en) * 1957-03-15 1959-01-20 Maxwell A Pollack Making alpha-chloroacrylic compounds
US3048615A (en) * 1957-12-30 1962-08-07 Standard Oil Co Tertiary alkyl azomethine copolymers
US3142698A (en) * 1960-10-03 1964-07-28 Borden Co Cyanoacrylate esters
US3282773A (en) * 1961-07-20 1966-11-01 Eastman Kodak Co Adhesive composition and method of bonding using alpha-cyanoacrylate esters and vinyl aromatics
US3554987A (en) * 1965-12-20 1971-01-12 Eastman Kodak Co Novel compounds and photographic materials containing said compounds
US3903055A (en) * 1972-12-21 1975-09-02 Johnson & Johnson Method for initiating polymerization of cyanoacrylate monomers and comonomer blends thereof to give reproducible and predetermined gel/transition time characteristics
US3975422A (en) * 1972-11-21 1976-08-17 Johnson & Johnson Preparation of bis (2-cyanoacrylate)monomers
US3988299A (en) * 1974-10-10 1976-10-26 Loctite Corporation Anaerobic adhesive composition having improved strength at elevated temperature consisting of unsaturated diacrylate monomer and maleimide additive
US3995641A (en) * 1975-04-23 1976-12-07 Ethicon, Inc. Surgical adhesives
US4003942A (en) * 1974-10-04 1977-01-18 Johnson & Johnson Blocked bis 2-cyanoacrylate monomers
US4012402A (en) * 1974-10-04 1977-03-15 Johnson & Johnson Modified cyanoacrylate monomers and methods for preparation
US4013703A (en) * 1974-10-04 1977-03-22 Johnson & Johnson Cyanoacrylic acid adducts
US4056543A (en) * 1976-09-07 1977-11-01 Eastman Kodak Company Process of preparing substituted acrylates
US4160864A (en) * 1976-09-07 1979-07-10 Eastman Kodak Company Adhesive compositions comprising methyl allyl methylenemalonate
US4202920A (en) * 1977-10-25 1980-05-13 Ciba-Geigy Corporation Cyanoacetic acid derivatives as epoxy resin curing agents
US4364876A (en) * 1980-03-27 1982-12-21 Toagosei Chemical Industry Co., Ltd. Novel 2-cyanoacrylate, process for producing same and curable composition comprising same
US4440910A (en) * 1982-01-18 1984-04-03 Loctite Corporation Toughened cyanoacrylates containing elastomeric rubbers
US4512357A (en) * 1983-01-12 1985-04-23 Fairchild Industries, Inc. Pressure transducer
US4556700A (en) * 1984-01-30 1985-12-03 Loctite Limited Instant adhesive composition utilizing calixarene accelerators
US4560723A (en) * 1983-11-14 1985-12-24 Minnesota Mining And Manufacturing Company Cyanoacrylate adhesive composition having sustained toughness
US4587059A (en) * 1983-04-07 1986-05-06 Henkel Kommanditgesellschaft Auf Aktien Process for production of 2-cyanoacrylates from 2,4-dicyanoglutarates
US4622414A (en) * 1984-01-27 1986-11-11 Loctite Limited Novel calixarene compounds
US4636539A (en) * 1984-01-30 1987-01-13 Loctite (Ireland) Limited Instant adhesive composition utilizing calixarene accelerators
US4695615A (en) * 1984-11-21 1987-09-22 Loctite (Ireland) Limited Instant adhesive composition utilizing mixed functionality calixarenes as accelerators
US4718966A (en) * 1984-01-30 1988-01-12 Loctite (Ireland) Ltd. Bonding method utilizing cyanoacrylate adhesive having calixarene accelerator
US4764545A (en) * 1986-01-10 1988-08-16 Ohara Paragium Chemical, Co., Ltd. Process for preparing α-cyanoacrylate type compounds and adhesive composition comprising α-cyanoacrylate type compound obtained by the process as its main component
US4837260A (en) * 1986-05-23 1989-06-06 Toagosei Chemical Industry Co., Ltd. Cyanoacrylate compositions
US4855461A (en) * 1987-01-21 1989-08-08 Loctite (Ireland) Ltd. Functionalized oxacalixarenes, their preparation and use in instant adhesive compositions
US4876045A (en) * 1987-09-11 1989-10-24 Farmitalia Carlo Erba S.R.L. Process for the preparation of methylene derivatives of androsta-1,4-diene-3,17-dione
US4906317A (en) * 1983-11-10 1990-03-06 Loctite Corporation Instant adhesive composition and bonding method employing same
US5142098A (en) * 1987-03-05 1992-08-25 Laboratoires Upsa Methylidenemalonate esters derived from esters of 9,10-endoethano-9,10-dihydroanthracane-11,11-dicarboxylic acid
US5288794A (en) * 1992-10-23 1994-02-22 Loctite Corporation Cyanoacrylate adhesives with improved cured thermal properties utilizing substituted aromatic additive
US5306752A (en) * 1992-10-09 1994-04-26 Loctite Corporation Cyanoacrylate adhesives utilizing quinoid compound polymer stabilizer
US5312864A (en) * 1990-03-26 1994-05-17 Henkel Kommanditgesellschaft Auf Aktien α-cyanoacrylate adhesive compositions
US5328944A (en) * 1992-07-14 1994-07-12 Loctite Corporation Cyanoacrylate adhesives with improved cured thermal properties
US5340873A (en) * 1991-08-23 1994-08-23 National Starch And Chemical Investment Holding Corporation Toughened cyanoacrylate adhesive composition containing polyester polymers
US5359101A (en) * 1989-11-21 1994-10-25 Loctite Ireland, Ltd. Anionically polymerizable monomers, polymers thereof and use of such polymers in photoresists
US5386047A (en) * 1994-03-11 1995-01-31 Loctite Corporation Di-α-cyanopentadienoate disiloxane compounds for use in adhesives
US5424344A (en) * 1994-01-05 1995-06-13 E. I. Dupont De Nemours And Company Flame retardant polyamide compositions
US5424343A (en) * 1992-10-08 1995-06-13 Loctite Corporation Thermally resistant cyanoacrylates employing substituted napthasultone additive
US5455369A (en) * 1994-12-02 1995-10-03 National Starch And Chemical Investment Holding Corporation Process for the manufacture of methyl cyanoacrylate
US5624699A (en) * 1991-07-22 1997-04-29 Processing Technologies International Ltd. Extraction method
US5703267A (en) * 1995-03-27 1997-12-30 Toagosei Co., Ltd. Process for producing 2-cyanoacrylic acid
US5744642A (en) * 1994-03-03 1998-04-28 Bayer Aktiengesellschaft Process for the preparation of aliphatic imines
US5994464A (en) * 1995-03-23 1999-11-30 Three Bond., Ltd. Cyanoacrylate adhesive composition
US6093780A (en) * 1998-10-02 2000-07-25 Loctite Corporation Cyanoacrylate adhesive compositions with improved cured thermal properties
US6096848A (en) * 1994-06-06 2000-08-01 Henkel Kommanditgesellschaft Auf Aktien Process for the production of biscyanoacrylates
US6174919B1 (en) * 1998-02-18 2001-01-16 Closure Medical Corporation Cyanoacrylate compositions with vinyl terminated ester groups
US6245933B1 (en) * 1999-11-19 2001-06-12 Closure Medical Corporation Transesterification method for making cyanoacrylates
US6291544B1 (en) * 1997-08-15 2001-09-18 Chemence, Inc. Reactive esters of 2-cyanopenta-2,4-dienoic acid and the adhesives and polymers thereof
US6531460B1 (en) * 1998-10-23 2003-03-11 Teijin Limited Vitamin D, derivatives and remedies for inflammatory respiratory diseases containing the same
US6833196B1 (en) * 2002-06-24 2004-12-21 Henkel Corporation Acrylic-toughened cyanoacrylate compositions
US6835789B1 (en) * 2003-06-18 2004-12-28 Loctite (R&D) Limited Cyanoacrylate compositions
US20060094833A1 (en) * 2004-11-01 2006-05-04 Loctite (R&D) Limited Shock resistant cyanoacrylate compositions
US20060269870A1 (en) * 2005-05-27 2006-11-30 Shin-Etsu Chemical Co., Ltd. Novel polymerizable ester compounds
US20080241249A1 (en) * 2007-03-30 2008-10-02 Closure Medical Corporation Cyanoacrylate composite

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3221745A (en) * 1962-09-12 1965-12-07 Eastman Kodak Co Method of bonding body tissue together using methylenemalonic acid esters
DE2626173C2 (en) 1976-06-11 1983-12-01 Bayer Ag, 5090 Leverkusen 2-Methylenopropane-1,3-diol-bis-acetic acid ester and its use
JPS59222462A (en) 1983-05-30 1984-12-14 Alpha Giken:Kk Novel alpha-cyanoacrylate compound, its preparation and adhesive composed of said compound
EP0267982A1 (en) 1986-11-18 1988-05-25 Wolfgang Baumann C-clamp
CA2027985A1 (en) 1989-10-27 1991-04-28 Koichiro Saeki Two-component type adhesive agent for wood
EP0459617A1 (en) 1990-04-27 1991-12-04 Three Bond Co., Ltd. Novel silicon containing alpha-cyanoacrylates
AU5714294A (en) * 1993-01-11 1994-08-15 Eurotax Limited Process for the preparation of esters of 2-cyanoacrylic acid and use of the esters so prepared as adhesives
WO1994015590A1 (en) 1993-01-11 1994-07-21 Abacol Limited Small diameter nanocapsules, process for their preparation and applications thereof
AU1671495A (en) 1994-05-24 1995-12-18 Saldane Limited Process for the preparation of 2-cyanoacryloyl chloride and use of the compound so prepared for the preparation of esters of 2-cyanoacrylic acid
JP3038922B2 (en) * 1995-05-30 2000-05-08 住友電気工業株式会社 Sliding component and method of manufacturing the same
MX214967B (en) 1997-09-17 2003-06-26 Ciba Sc Holding Ag MORPHOLINS AS STABILIZERS OF LIGHT
JPH11106372A (en) * 1997-10-01 1999-04-20 Toagosei Co Ltd New 2-cyanoacrylate
US6310166B1 (en) 1999-08-12 2001-10-30 Closure Medical Corporation Sterilized cyanoacrylate solutions containing thickeners
US6627220B2 (en) 2001-07-13 2003-09-30 Scolr, Inc. Tablets containing heat sensitive materials and method for forming thereof
EP2258706A3 (en) 2002-04-05 2011-10-12 University Of South Alabama Functionalized ionic liquids, and methods of use thereof

Patent Citations (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2363464A (en) * 1942-04-29 1944-11-21 Commercial Solvents Corp Beta-aminoalkyl acetals
US2415046A (en) * 1944-04-21 1947-01-28 Commercial Solvents Corp Acetals of nitro alcohols
US2413249A (en) * 1945-05-07 1946-12-24 Commercial Solvents Corp 1,5-bis-(1-nitro-3,5-dioxacyclohexyl)-2,4 dioxapentane
US2413250A (en) * 1945-05-07 1946-12-24 Commercial Solvents Corp 1,5-bis (1-amino-3,5-dioxacyclohexyl) 2,4 dioxapentane
US2582128A (en) * 1950-02-11 1952-01-08 Rohm & Haas Aldimines
US2721858A (en) * 1954-03-10 1955-10-25 Eastman Kodak Co Method of making alpha-cyanoacrylates
US2756251A (en) * 1954-03-23 1956-07-24 Eastman Kodak Co Preparation of monomeric alpha-cyanoacrylates
US2763677A (en) * 1954-12-20 1956-09-18 Eastman Kodak Co Process for making monomeric alpha-cyanoacrylates
US2870193A (en) * 1957-03-15 1959-01-20 Maxwell A Pollack Making alpha-chloroacrylic compounds
US3048615A (en) * 1957-12-30 1962-08-07 Standard Oil Co Tertiary alkyl azomethine copolymers
US3142698A (en) * 1960-10-03 1964-07-28 Borden Co Cyanoacrylate esters
US3282773A (en) * 1961-07-20 1966-11-01 Eastman Kodak Co Adhesive composition and method of bonding using alpha-cyanoacrylate esters and vinyl aromatics
US3554987A (en) * 1965-12-20 1971-01-12 Eastman Kodak Co Novel compounds and photographic materials containing said compounds
US3975422A (en) * 1972-11-21 1976-08-17 Johnson & Johnson Preparation of bis (2-cyanoacrylate)monomers
US3903055A (en) * 1972-12-21 1975-09-02 Johnson & Johnson Method for initiating polymerization of cyanoacrylate monomers and comonomer blends thereof to give reproducible and predetermined gel/transition time characteristics
US4013703A (en) * 1974-10-04 1977-03-22 Johnson & Johnson Cyanoacrylic acid adducts
US4003942A (en) * 1974-10-04 1977-01-18 Johnson & Johnson Blocked bis 2-cyanoacrylate monomers
US4012402A (en) * 1974-10-04 1977-03-15 Johnson & Johnson Modified cyanoacrylate monomers and methods for preparation
US3988299A (en) * 1974-10-10 1976-10-26 Loctite Corporation Anaerobic adhesive composition having improved strength at elevated temperature consisting of unsaturated diacrylate monomer and maleimide additive
US3995641A (en) * 1975-04-23 1976-12-07 Ethicon, Inc. Surgical adhesives
US4056543A (en) * 1976-09-07 1977-11-01 Eastman Kodak Company Process of preparing substituted acrylates
US4160864A (en) * 1976-09-07 1979-07-10 Eastman Kodak Company Adhesive compositions comprising methyl allyl methylenemalonate
US4202920A (en) * 1977-10-25 1980-05-13 Ciba-Geigy Corporation Cyanoacetic acid derivatives as epoxy resin curing agents
US4364876A (en) * 1980-03-27 1982-12-21 Toagosei Chemical Industry Co., Ltd. Novel 2-cyanoacrylate, process for producing same and curable composition comprising same
US4440910A (en) * 1982-01-18 1984-04-03 Loctite Corporation Toughened cyanoacrylates containing elastomeric rubbers
US4512357A (en) * 1983-01-12 1985-04-23 Fairchild Industries, Inc. Pressure transducer
US4587059A (en) * 1983-04-07 1986-05-06 Henkel Kommanditgesellschaft Auf Aktien Process for production of 2-cyanoacrylates from 2,4-dicyanoglutarates
US4906317A (en) * 1983-11-10 1990-03-06 Loctite Corporation Instant adhesive composition and bonding method employing same
US4560723A (en) * 1983-11-14 1985-12-24 Minnesota Mining And Manufacturing Company Cyanoacrylate adhesive composition having sustained toughness
US4622414A (en) * 1984-01-27 1986-11-11 Loctite Limited Novel calixarene compounds
US4636539A (en) * 1984-01-30 1987-01-13 Loctite (Ireland) Limited Instant adhesive composition utilizing calixarene accelerators
US4556700A (en) * 1984-01-30 1985-12-03 Loctite Limited Instant adhesive composition utilizing calixarene accelerators
US4718966A (en) * 1984-01-30 1988-01-12 Loctite (Ireland) Ltd. Bonding method utilizing cyanoacrylate adhesive having calixarene accelerator
US4695615A (en) * 1984-11-21 1987-09-22 Loctite (Ireland) Limited Instant adhesive composition utilizing mixed functionality calixarenes as accelerators
US4764545A (en) * 1986-01-10 1988-08-16 Ohara Paragium Chemical, Co., Ltd. Process for preparing α-cyanoacrylate type compounds and adhesive composition comprising α-cyanoacrylate type compound obtained by the process as its main component
US4837260A (en) * 1986-05-23 1989-06-06 Toagosei Chemical Industry Co., Ltd. Cyanoacrylate compositions
US4855461A (en) * 1987-01-21 1989-08-08 Loctite (Ireland) Ltd. Functionalized oxacalixarenes, their preparation and use in instant adhesive compositions
US5142098A (en) * 1987-03-05 1992-08-25 Laboratoires Upsa Methylidenemalonate esters derived from esters of 9,10-endoethano-9,10-dihydroanthracane-11,11-dicarboxylic acid
US4876045A (en) * 1987-09-11 1989-10-24 Farmitalia Carlo Erba S.R.L. Process for the preparation of methylene derivatives of androsta-1,4-diene-3,17-dione
US5359101A (en) * 1989-11-21 1994-10-25 Loctite Ireland, Ltd. Anionically polymerizable monomers, polymers thereof and use of such polymers in photoresists
US5312864A (en) * 1990-03-26 1994-05-17 Henkel Kommanditgesellschaft Auf Aktien α-cyanoacrylate adhesive compositions
US5624699A (en) * 1991-07-22 1997-04-29 Processing Technologies International Ltd. Extraction method
US5340873A (en) * 1991-08-23 1994-08-23 National Starch And Chemical Investment Holding Corporation Toughened cyanoacrylate adhesive composition containing polyester polymers
US5328944A (en) * 1992-07-14 1994-07-12 Loctite Corporation Cyanoacrylate adhesives with improved cured thermal properties
US5424343A (en) * 1992-10-08 1995-06-13 Loctite Corporation Thermally resistant cyanoacrylates employing substituted napthasultone additive
US5306752A (en) * 1992-10-09 1994-04-26 Loctite Corporation Cyanoacrylate adhesives utilizing quinoid compound polymer stabilizer
US5288794A (en) * 1992-10-23 1994-02-22 Loctite Corporation Cyanoacrylate adhesives with improved cured thermal properties utilizing substituted aromatic additive
US5424344A (en) * 1994-01-05 1995-06-13 E. I. Dupont De Nemours And Company Flame retardant polyamide compositions
US5744642A (en) * 1994-03-03 1998-04-28 Bayer Aktiengesellschaft Process for the preparation of aliphatic imines
US5386047A (en) * 1994-03-11 1995-01-31 Loctite Corporation Di-α-cyanopentadienoate disiloxane compounds for use in adhesives
US6096848A (en) * 1994-06-06 2000-08-01 Henkel Kommanditgesellschaft Auf Aktien Process for the production of biscyanoacrylates
US5455369A (en) * 1994-12-02 1995-10-03 National Starch And Chemical Investment Holding Corporation Process for the manufacture of methyl cyanoacrylate
US5994464A (en) * 1995-03-23 1999-11-30 Three Bond., Ltd. Cyanoacrylate adhesive composition
US5703267A (en) * 1995-03-27 1997-12-30 Toagosei Co., Ltd. Process for producing 2-cyanoacrylic acid
US6291544B1 (en) * 1997-08-15 2001-09-18 Chemence, Inc. Reactive esters of 2-cyanopenta-2,4-dienoic acid and the adhesives and polymers thereof
US6174919B1 (en) * 1998-02-18 2001-01-16 Closure Medical Corporation Cyanoacrylate compositions with vinyl terminated ester groups
US6093780A (en) * 1998-10-02 2000-07-25 Loctite Corporation Cyanoacrylate adhesive compositions with improved cured thermal properties
US6531460B1 (en) * 1998-10-23 2003-03-11 Teijin Limited Vitamin D, derivatives and remedies for inflammatory respiratory diseases containing the same
US6245933B1 (en) * 1999-11-19 2001-06-12 Closure Medical Corporation Transesterification method for making cyanoacrylates
US6833196B1 (en) * 2002-06-24 2004-12-21 Henkel Corporation Acrylic-toughened cyanoacrylate compositions
US6835789B1 (en) * 2003-06-18 2004-12-28 Loctite (R&D) Limited Cyanoacrylate compositions
US20060094833A1 (en) * 2004-11-01 2006-05-04 Loctite (R&D) Limited Shock resistant cyanoacrylate compositions
US20060269870A1 (en) * 2005-05-27 2006-11-30 Shin-Etsu Chemical Co., Ltd. Novel polymerizable ester compounds
US20080241249A1 (en) * 2007-03-30 2008-10-02 Closure Medical Corporation Cyanoacrylate composite

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10196471B1 (en) * 2008-10-24 2019-02-05 Henkel IP & Holding GmbH Curable composition having an electron deficient olefin
WO2013113035A1 (en) 2012-01-28 2013-08-01 Optmed, Inc. Improved methylidene malonate process
WO2013113037A1 (en) 2012-01-28 2013-08-01 Optmed, Inc. Improved 1, 1-disubstituted ethylene process
US20150158807A1 (en) * 2012-01-28 2015-06-11 Optmed, Inc. Methylidene malonate process
US10597355B2 (en) 2012-01-28 2020-03-24 Optmed, Inc. 1,1-disubstituted ethylene process
US11555011B2 (en) 2012-01-28 2023-01-17 H.B. Fuller Company 1,1-disubstituted ethylene process
TWI511943B (en) * 2014-03-31 2015-12-11 Afinitica Technologies S L Process for preparing 1,1-disubstituted ethylene monomers
WO2021150844A1 (en) 2020-01-24 2021-07-29 Sirrus, Inc. Compositions containing 1,1-disubstituted activated alkenes useful in additive manufacturing and articles formed therefrom

Also Published As

Publication number Publication date
ES2634631T3 (en) 2017-09-28
CN102083784A (en) 2011-06-01
EP2217559A2 (en) 2010-08-18
EP2217559B1 (en) 2017-06-28
JP5639892B2 (en) 2014-12-10
US20150191424A1 (en) 2015-07-09
US20160075641A1 (en) 2016-03-17
JP2011500769A (en) 2011-01-06
CA2703603A1 (en) 2009-04-30
US9481640B2 (en) 2016-11-01
KR20100097116A (en) 2010-09-02
KR101571913B1 (en) 2015-11-25
WO2009053484A2 (en) 2009-04-30
WO2009053484A3 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
US9481640B2 (en) Electron deficient olefins
EP2217557B1 (en) Activated methylene reagents
EP2086927B1 (en) Iminium salts and methods of preparing electron deficient olefins using such novel iminium salts
US7659423B1 (en) Method of preparing electron deficient olefins in polar solvents
US7718821B1 (en) Method of preparing electron deficient olefins
US7569719B1 (en) Method of preparing electron deficient olefins
US9365750B2 (en) Accelerators for curable compositions
US8053589B1 (en) Imines and methods of preparing electron deficient olefins using such novel imines
US20140155556A1 (en) Adhesive systems using imines and salts thereof, precursors to electron deficient olefins and coreactants therefor
US8986847B2 (en) Accelerator/oxidant/proton source combinations for two part curable compositions
EP0151527B1 (en) Instant adhesive composition utilizing calixarene accelerators
US7973119B1 (en) Adhesive systems using imines and salts thereof and precursurs to electron deficient olefins
US10927071B2 (en) Process for preparing electron deficient olefins
US10196471B1 (en) Curable composition having an electron deficient olefin
US8399698B1 (en) Substituted activated methylene reagents and methods of using such reagents to form electron deficient olefins

Legal Events

Date Code Title Description
AS Assignment

Owner name: HENKEL IRELAND LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MCARDLE, CIARAN B.;ZHAO, LIGANG;GHERARDI, STEFANO L.;AND OTHERS;REEL/FRAME:031340/0079

Effective date: 20100820

Owner name: LOCTITE (R&D) LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HENKEL IRELAND LIMITED;REEL/FRAME:031340/0153

Effective date: 20101108

AS Assignment

Owner name: HENKEL IRELAND LIMITED, GERMANY

Free format text: MERGER;ASSIGNOR:HENKEL IRELAND HOLDING B.V.;REEL/FRAME:031496/0560

Effective date: 20111122

Owner name: HENKEL IRELAND HOLDING B.V., IRELAND

Free format text: MERGER;ASSIGNOR:LOCTITE (R&D) LIMITED;REEL/FRAME:031496/0233

Effective date: 20111121

AS Assignment

Owner name: HENKEL IP & HOLDING GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HENKEL AG & CO. KGAA;REEL/FRAME:032329/0172

Effective date: 20131121

Owner name: HENKEL AG & CO. KGAA, GERMANY

Free format text: MERGER;ASSIGNOR:HENKEL IRELAND LIMITED;REEL/FRAME:032329/0132

Effective date: 20130829

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION